First image of the tested substance
First image of the tested substance
Second image of the tested substance
First image of the tested substance
Second image of the tested substance
Second image of the tested substance

Active ingredients and content

Flubromazolam

qualitative

Details of the substance tested

Thickness

3.3 mm

Length x width

15.2 x 5.1 mm

Diameter

Weight

300 mg

Colour

White

Colour

White

Fracture groove

Yes

Relevant substance(s)

Alprazolam (Xanax®)

Learn more

Risk assessment

This tablet, sold as Xanax, did not contain the expected benzodiazepine alprazolam, but flubromazolam.

Flubromazolam is a very potent New Psychoactive Substance(NPS) from the benzodiazepine group and has never been researched and approved for human use. Flubromazolam is dosed lower and has a longer duration of action than the active ingredient alprazolam contained in Xanax. For this reason, there is a risk of overdose if these substances are misdeclared. Flubromazolam has an even higher dependence potential compared to other benzodiazepines.

Mixed use with other depressant substances and dissociatives can lead to unconsciousness and life-threatening respiratory depression.

Flubromazolam is an unresearched substance. There is hardly any reliable information on risks, toxicity, side effects and long-term consequences.

Consumption is not advised!

Alert level

Safer Use

Analysis

Have your substances tested in a drug check.

Testing

If you do not have the possibility to have substances analyzed, first test a maximum of one third of the pill, since very many high-dose pills are in circulation.

Wait and see

Wait 2 hours after taking the medication, as there are always pills with unexpected active ingredients in circulation, which can have a later onset of action.

Drinking

Remember: drink non-alcoholic and isotonic drinks (3 dl / hour) and take breaks in the fresh air from time to time to prevent overheating / dehydration.

Similar warnings

There are no current warnings for this substance

Things to know